These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11752619)

  • 1. NF-kappa B defects in humans: the NEMO/incontinentia pigmenti connection.
    Courtois G; Israël A
    Sci STKE; 2000 Nov; 2000(58):pe1. PubMed ID: 11752619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
    Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
    J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
    Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
    Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
    Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incontinentia pigmenti: a window to the role of NF-kappaB function.
    Bruckner AL
    Semin Cutan Med Surg; 2004 Jun; 23(2):116-24. PubMed ID: 15295921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEMO/IKK gamma-deficient mice model incontinentia pigmenti.
    Schmidt-Supprian M; Bloch W; Courtois G; Addicks K; Israël A; Rajewsky K; Pasparakis M
    Mol Cell; 2000 Jun; 5(6):981-92. PubMed ID: 10911992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.
    Berlin AL; Paller AS; Chan LS
    J Am Acad Dermatol; 2002 Aug; 47(2):169-87; quiz 188-90. PubMed ID: 12140463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The consequences of incontinentia pigmenti.
    Greaves S
    Nat Cell Biol; 2000 Aug; 2(8):E144. PubMed ID: 10934485
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel inhibitor of nuclear factor kappa-B kinase subunit gamma mutation identified in an incontinentia pigmenti patient with syndromic tooth agenesis.
    Sun S; Li F; Liu Y; Qu H; Wong SW; Zeng L; Yu M; Feng H; Liu H; Han D
    Arch Oral Biol; 2019 May; 101():100-107. PubMed ID: 30913450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
    Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
    J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.
    Fusco F; Bardaro T; Fimiani G; Mercadante V; Miano MG; Falco G; Israël A; Courtois G; D'Urso M; Ursini MV
    Hum Mol Genet; 2004 Aug; 13(16):1763-73. PubMed ID: 15229184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
    Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
    Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two neonates with vesicular skin lesions due to incontinentia pigmenti].
    Winterberg DH; van Tijn DA; Smitt JH; Winterberg S; Vomberg PP
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2178-82. PubMed ID: 11727618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.
    Conte MI; Pescatore A; Paciolla M; Esposito E; Miano MG; Lioi MB; McAleer MA; Giardino G; Pignata C; Irvine AD; Scheuerle AE; Royer G; Hadj-Rabia S; Bodemer C; Bonnefont JP; Munnich A; Smahi A; Steffann J; Fusco F; Ursini MV
    Hum Mutat; 2014 Feb; 35(2):165-77. PubMed ID: 24339369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From gene to disease; incontinentia pigmenti and the NEMO-gene].
    Oranje AP; Arts WF; Wagner A; van der Hout AH; Simonsz HJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1682-5. PubMed ID: 16104114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.
    Rudolph D; Yeh WC; Wakeham A; Rudolph B; Nallainathan D; Potter J; Elia AJ; Mak TW
    Genes Dev; 2000 Apr; 14(7):854-62. PubMed ID: 10766741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.
    Aradhya S; Woffendin H; Jakins T; Bardaro T; Esposito T; Smahi A; Shaw C; Levy M; Munnich A; D'Urso M; Lewis RA; Kenwrick S; Nelson DL
    Hum Mol Genet; 2001 Sep; 10(19):2171-9. PubMed ID: 11590134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo incontinentia pigmenti in female twins.
    Su PH; Chen JY; Yu JS; Su CM; Huang TC; Chen SJ
    Acta Paediatr Taiwan; 2004; 45(3):178-80. PubMed ID: 15493740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.